<img height="1" width="1" style="display:none;" alt="" src="https://dc.ads.linkedin.com/collect/?pid=412980&amp;fmt=gif">
LSX-Blog.png

Something Powerful

Tell The Reader More

The headline and subheader tells us what you're offering, and the form header closes the deal. Over here you can explain why your offer is so great it's worth filling out a form for.

Remember:

  • Bullets are great
  • For spelling out benefits and
  • Turning visitors into leads.

Key challenges to scaling up early-stage investmen...

Access to venture capital and effective fundraising tactics are key to buil...

Read More

Brexit: finite uncertainty

One might think that planning for uncertainty is something that biotech fir...

Read More

Interview with Avacta Group's Alastair Smith

In this video, Donald Leggatt, Head of Investor Relations at London South E...

Read More

Growing opportunities in cannabinoid-based treatme...

In June 2018 it was announced that venture capital firm Casa Verde Capital,...

Read More

Make Brexit a non-issue for pharma

What is the recipe for keeping business momentum in clinical trials despite...

Read More

Technical notices for a ‘no-deal’ Brexit

The UK government issued a series of ‘technical notices’ on 23 August outli...

Read More

CMR Surgical prepares for commercialisation on the...

Key findings: In June 2018, surgical robotics company CMR Surgical raised $...

Read More

Exploring IP best practice in UK life sciences

In 2017, the East of England filed 623 patents via the European Patent Offi...

Read More

Does Brexit affect your European patent strategy?

The process of obtaining patent protection in Europe is unaffected by Brexi...

Read More

PharmaKrysto kickstarts cystinuria drug developmen...

Key learnings: PharmaKrysto has signed a licensing deal with Rutgers Univer...

Read More

PhoreMost raises £11m Series A round to progress t...

Key learnings: PhoreMost completed its Series A round in May 2018, with a t...

Read More

Investorview: Driving early-stage investment in UK...

In March 2018, NCL Technology Ventures launched a £50 million fund to help ...

Read More

Add Your Response